Health service use costs and consequences by allocated group over 6 months
| Intervention kits (n=158) Mean (SD) | Treatment as usual (n=75) Mean (SD) | Intervention minus treatment as usual (bootstrapped 95% CIs) | |
| Costs | |||
| Primary care (£)* | 67 (111) | 61 (90) | 6 (−22 to 32) |
| Secondary care (£)* | 454 (524) | 504 (648) | −50 (−226 to 103) |
| EPIC intervention cost (£)*† | 181 (4) | 0 (0) | 181 |
| Total cost/participant (£) | 702 (558) | 566 (664) | 136 (−52 to 296) |
| Consequences | |||
| Participant self-report | |||
| QALYs | 0.446 (0.0741) | 0.447 (0.0784) | −0.001 (−0.0209 to 0.0189) |
| Parent-proxy | |||
| QALYs | 0.415 (0.0785) | 0.418 (0.0831) | −0.003 (−0.0238 to 0.0188) |
*Mean (SD) total cost per participant (£).
†Cost of intervention includes the ‘treatment costs’ of producing and distributing the kit to participants by Paediatric Diabetes Specialist Nurses in clinics; those of producing and distributing the intervention diabetes diary; but not the ‘research costs’ of developing kit or diary.
EPIC, Evidence into Practice—Information Counts; QALYs, Quality Adjusted Life Years.